dc.contributor.author |
Gouttefangeas, Cécile |
|
dc.contributor.author |
Kalbacher, Hubert |
|
dc.date.accessioned |
2016-01-11T16:38:57Z |
|
dc.date.available |
2016-01-11T16:38:57Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
0340-7004 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/67479 |
|
dc.language.iso |
en |
en |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s00262-015-1717-1 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.title |
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20151209042647_00829 |
|
utue.publikation.seiten |
1123-1136 |
de_DE |
utue.personen.roh |
Anastasopoulou, Eleftheria A. |
|
utue.personen.roh |
Voutsas, Ioannis F. |
|
utue.personen.roh |
Keramitsoglou, Theodora |
|
utue.personen.roh |
Gouttefangeas, Cecile |
|
utue.personen.roh |
Kalbacher, Hubert |
|
utue.personen.roh |
Thanos, Anastasios |
|
utue.personen.roh |
Papamichail, Michael |
|
utue.personen.roh |
Perez, Sonia A. |
|
utue.personen.roh |
Baxevanis, Constantin N. |
|
dcterms.isPartOf.ZSTitelID |
Cancer Immunology Immunotherapy |
de_DE |
dcterms.isPartOf.ZS-Issue |
9 |
de_DE |
dcterms.isPartOf.ZS-Volume |
64 |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
|
utue.fakultaet |
04 Medizinische Fakultät |
|
utue.fakultaet |
Sonstige |
|